Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacology

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000471769PMID 28482342PMCID PMC5884074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction to: Adenosine Monophosphate-Activated Protein Kinase-α2 Deficiency Promotes Vascular Smooth Muscle Cell Migration via S-Phase Kinase-Associated Protein 2 Upregulation and E-Cadherin Downregulation.

  2019cited by this paper
• Sulforaphane inhibits platelet‐derived growth factor‐induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation

  2017cited by this paper
• Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.

  2016cited by this paper
• Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway

  2016cited by this paper
• Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice.

  2016cited by this paper
• Adipose‐derived protein omentin prevents neointimal formation after arterial injury

  2015cited by this paper
• AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1

  2015cited by this paper
• RORα suppresses proliferation of vascular smooth muscle cells through activation of AMP-activated protein kinase.

  2014cited by this paper
• AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

  2013cited by this paper
• AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?

  2013cited by this paper
• Adenosine Monophosphate–Activated Protein Kinase-&agr;2 Deficiency Promotes Vascular Smooth Muscle Cell Migration via S-Phase Kinase–Associated Protein 2 Upregulation and E-Cadherin Downregulation

  2013cited by this paper
• The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats

  2013cited by this paper
• Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.

  2012cited by this paper
• Circulation Research Thematic Synopsis: Atherosclerosis

  2012cited by this paper
• Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.

  2012cited by this paper
• Role of pioglitazone in the prevention of restenosis and need for revascularization after bare-metal stent implantation: a meta-analysis.

  2011cited by this paper
• Adiponectin Induces Vascular Smooth Muscle Cell Differentiation via Repression of Mammalian Target of Rapamycin Complex 1 and FoxO4

  2011cited by this paper
• Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.

  2011cited by this paper
• Compound C Inhibits Vascular Smooth Muscle Cell Proliferation and Migration in an AMP-Activated Protein Kinase-Independent Fashion

  2011cited by this paper
• Adenosine Monophosphate Activated Protein Kinase Regulates ABCG1-Mediated Oxysterol Efflux From Endothelial Cells and Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction

  2010cited by this paper
• Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPARγ

  2010cited by this paper
• Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPAR&ggr;

  2010cited by this paper
• Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling

  2009cited by this paper
• Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia: Activation of Glycogen Synthase Kinase-3&bgr; Followed by Inhibition of MMP-9

  2009cited by this paper
• New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia

  2009cited by this paper
• Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

  2009cited by this paper
• AMP-activated Protein Kinase Phosphorylates and Desensitizes Smooth Muscle Myosin Light Chain Kinase*♦

  2008cited by this paper
• Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome.

  2007cited by this paper
• Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.

  2007cited by this paper
• Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice

  2007cited by this paper
• A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes.

  2006cited by this paper
• PPARγ Gene Transfer Sustains Apoptosis, Inhibits Vascular Smooth Muscle Cell Proliferation, and Reduces Neointima Formation After Balloon Injury in Rats

  2006cited by this paper
• Peroxisome Proliferator-Activated Receptor γ Ligand Pioglitazone Alters Neointimal Composition in a Balloon-Denuded and Radiated Hypercholesterolemic Rabbit

  2006cited by this paper
• Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

  2006cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption

  2005cited by this paper
• Edema and Congestive Heart Failure from Thiazolidone Insulin Sensitizers—Excess Sodium Reabsoption in the Collecting Duct Collecting Duct-Specific Deletion of Peroxisome Proliferator-Activated Receptor γ Blocks Thiazolidinedione-Induced Fluid Retention. Proc Nat Acad Sci U S A 102: 9406–9411, 2005

  2005cited by this paper
• Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

  2005cited by this paper
• Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

  2005cited by this paper
• Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

  2004cited by this paper
• Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

  2004cited by this paper
• Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-&ggr; Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation

  2003cited by this paper
• Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 Diabetes

  2003cited by this paper
• Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

  2003cited by this paper
• Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect.

  2003cited by this paper
• Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement From the American Heart Association and American Diabetes Association

  2003cited by this paper
• Pioglitazone Enhances Cytokine-Induced Apoptosis in Vascular Smooth Muscle Cells and Reduces Intimal Hyperplasia

  2001cited by this paper
• Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells

  2000cited by this paper
• A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia.

  2000cited by this paper
• Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

  2000cited by this paper
• Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.

  2000cited by this paper
• Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.

  1998cited by this paper
• Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

  1996cited by this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995cited by this paper

• The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells

  2023cites this paper
• Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions

  2022cites this paper
• Lipotoxicity, glucotoxicity and some strategies to protect vascular smooth muscle cell against proliferative phenotype in metabolic syndrome.

  2022cites this paper
• TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake

  2019cites this paper
• ROS-mediated autophagy through the AMPK signaling pathway protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity

  2018cites this paper